Target intelligence / Profile preview

RAPGEF4 antisense RNA 1 (RAPGEF4-AS1)

Target
RAPGEF4-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

RAPGEF4 antisense RNA 1 (RAPGEF4-AS1) is a long non-coding RNA (lncRNA) gene located antisense to the RAPGEF4 coding gene. As defined by the HUGO Gene Nomenclature Committee, antisense RNAs are lncRNAs that are transcribed from the opposite strand of a protein-coding gene and may be involved in the regulation of that gene’s expression[4]. RAPGEF4-AS1 is a non-protein-coding RNA; its precise biological function, molecular targets, and role in disease remain uncharacterized as of current databases and gene annotations[7].\n\nKey details:\n- Currently, there is no evidence indicating RAPGEF4-AS1 itself acts as a therapeutic target, receptor, enzyme, transporter, or similar druggable entity.\n- There are no known drugs, biomarkers, or mechanisms of action associated with this RNA gene.\n- Databases do sometimes list lncRNAs as potential disease regulators, but as of this search, RAPGEF4-AS1 lacks any such validated association.\n- If future studies identify a function or role in disease, this information may change; currently, the entry follows available evidence[7][4].

Other names
RAPGEF4-AS1RAPGEF4 antisense RNA 1 (non-protein coding)RAPGEF4 antisense RNA 1
02

Biological functions

Unknownpossible regulation of RAPGEF4 gene expression (inferred from antisense location and molecular class)
03

Disease associations

Unknown (no direct evidence or disease associations currently cited for RAPGEF4-AS1; unlike many lncRNAs, no reports suggest direct disease involvement as of now)

Beyond the preview

Go deeper on RAPGEF4 antisense RNA 1 (RAPGEF4-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAPGEF4 antisense RNA 1 (RAPGEF4-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call